United Therapeutics Corporation To Report Third Quarter 2020 Financial Results Before The Market Opens On Wednesday, October 28, 2020
United Therapeutics Corporation To Report Third Quarter 2020 Financial Results Before The Market Opens On Wednesday, October 28, 2020 |
[21-October-2020] |
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2020 financial results before the market opens on Wednesday, October 28, 2020. United Therapeutics will host a teleconference on Wednesday, October 28, 2020, at 9:00 a.m. Eastern Time. The teleconference is accessible by dialing (866) 209-9943 in the United States, with international callers dialing +1 (825) 312-2282. A rebroadcast of the teleconference will be available for one week and can be accessed by dialing (800) 585-8367 in the United States, with international callers dialing +1 (416) 621-4642, and using access code: 8782637. This teleconference is also being webcast and can be accessed via United Therapeutics' website at https://ir.unither.com/events-and-presentations. About United Therapeutics Through our wholly owned subsidiary, Lung Biotechnology PBC, we are focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Lung Biotechnology is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company. Forward-Looking Statements For Further Information Contact: View original content:http://www.prnewswire.com/news-releases/united-therapeutics-corporation-to-report-third-quarter-2020-financial-results-before-the-market-opens-on-wednesday-october-28-2020-301156271.html SOURCE United Therapeutics Corporation | ||
Company Codes: NASDAQ-NMS:UTHR |
© 2020 PR Newswire. All Rights Reserved.